Evert B. Schimmelpennink
President, CEO and Secretary at LENZ Therapeutics Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2024
7 years of board service in total across 3 boards, counting each seat separately. Longest: LENZ Therapeutics Inc., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Contineum Therapeutics Inc. June 26, 202699.4%
-
LENZ Therapeutics Inc. June 12, 202698.9%
-
iBio Inc. November 21, 202494.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | LENZ Therapeutics Inc. | Open-market purchase | +28,089 | $8.95 | $251,397 |
| Mar 7, 2025 | LENZ Therapeutics Inc. | Option exercise | +4,200 | $1.04 | $4,368 |
| Jul 22, 2024 | LENZ Therapeutics Inc. | Option exercise | +45,000 | $1.04 | $46,800 |
Questions about Evert B. Schimmelpennink
What boards is Evert B. Schimmelpennink on?
Evert B. Schimmelpennink sits on the boards of Contineum Therapeutics Inc., LENZ Therapeutics Inc. and iBio Inc.
What company is Evert B. Schimmelpennink the CEO of?
Evert B. Schimmelpennink has been President, CEO and Secretary of LENZ Therapeutics Inc. since March 2024.
How long has Evert B. Schimmelpennink served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.